- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04874766
The Effects of Wearing a Face Mask During Exercise in Youth Hockey Players During COVID-19
October 19, 2021 updated by: Phil Chilibeck, University of Saskatchewan
The Effects of Wearing a Face Mask on Exercise Tolerance in Children's Hockey During the COVID-19 Pandemic
There is concern that wearing a face mask during COVID will affect oxygen uptake, especially during intense exercise.
COVID transmission is especially prevalent in sports such as hockey, where there is close contact between players and arena ventilation is poor.
This study will assess the effect of wearing a surgical face mask on simulated hockey performance and blood and muscle oxygenation during cycling exercise.
Study Overview
Status
Completed
Conditions
Detailed Description
The sport of ice hockey involves close contact between players in poorly ventilated arenas.
This increases susceptibility for transmission of viruses, such as COVID-19.
Face masks can reduce the risk of virus transmission; however, there is concern that wearing a face mask during exercise will reduce oxygen uptake or increase carbon dioxide re-breathing, which can result in low blood oxygen levels, reduced oxygen delivery to muscle and reduced exercise capacity.
The purpose of the study is to determine the effect of wearing a surgical face mask during exercise that simulates ice hockey play on exercise performance and blood and muscle oxygenation in boys and girls.
Twelve boys and twelve girls (age 9-14y) who are experienced playing hockey, will take part in this randomized cross-over study that will assess exercise performance, blood oxygenation (i.e.
pulse oximetry) and muscle oxygenation (with near infrared spectroscopy) during an exercise test on a cycle ergometer with workloads and work to rest intervals that simulates hockey performance.
Participants will also be tested for repeated-sprint performance on ice while wearing full hockey equipment.
The conditions include no mask (a "sham" mask) and a surgical mask.
Outcome variables include power output during the cycle ergometer testing, skating distance during the on-ice test, rating of perceived exertion, blood oxygen saturation levels, and oxygenated, deoxygenated, and total hemoglobin at the quadriceps muscle.
Study Type
Interventional
Enrollment (Actual)
26
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Canada, S7N5B2
- University of Saskatchewan
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
9 years to 14 years (Child)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Experience playing ice-hockey
Exclusion Criteria:
- Contra-indications to exercise as identified by a screening questionnaire (the "Get Active Questionnaire")
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Surgical face mask
Simulated hockey period with 2x20s Wingate tests; progressive-intensity on-ice sprint test while wearing a surgical mask
|
Power output during 2 x 20s Wingate cycle tests and total distance during an on-ice skating test while wearing a face mask
|
|
Sham Comparator: Sham face mask
Simulated hockey period with 2x20s Wingate tests; progressive-intensity on-ice sprint test while wearing a sham mask
|
Power output during 2 x 20s Wingate cycle tests and total distance during an on-ice skating test while wearing a face mask
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in average power output
Time Frame: Up to 40 seconds
|
Average power output in Watts during two 20 second Wingate tests
|
Up to 40 seconds
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline in peak power output
Time Frame: Up to 40 seconds
|
Peak power output in Watts during two 20 second Wingate tests
|
Up to 40 seconds
|
|
Change from baseline in on-ice sprint testing distance
Time Frame: Up to 12 minutes
|
Distance in meters covered during a repeated 20-meter sprint test that progressively increases in speed
|
Up to 12 minutes
|
|
Change from baseline in blood oxygen saturation
Time Frame: Up to 40 minutes
|
Blood oxygen saturation (%) determined by pulse oximetry
|
Up to 40 minutes
|
|
Change from baseline in quadriceps tissue oxygenation index
Time Frame: Up to 40 minutes
|
Tissue oxygenation index (oxygenated hemoglobin/total hemoglobin) as measured by near infra-red spectroscopy
|
Up to 40 minutes
|
|
Change from baseline in rating of perceived exertion
Time Frame: Up to 40 minutes
|
Rating of perceived exertion on a scale of 1-10 (Modified Borg Scale), a higher score indicates a greater perceived exertion
|
Up to 40 minutes
|
|
Change from baseline in heart rate
Time Frame: Up to 40 minutes
|
Heart rate (beats per minute)
|
Up to 40 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 28, 2021
Primary Completion (Actual)
July 15, 2021
Study Completion (Actual)
August 31, 2021
Study Registration Dates
First Submitted
April 23, 2021
First Submitted That Met QC Criteria
May 2, 2021
First Posted (Actual)
May 6, 2021
Study Record Updates
Last Update Posted (Actual)
October 25, 2021
Last Update Submitted That Met QC Criteria
October 19, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2701
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypoxemia
-
General Hospital of Ningxia Medical UniversityWuzhong City People's Hospital; Yinchuan Traditional Chinese Medicine Hospital and other collaboratorsRecruiting
-
Inogen Inc.CompletedNocturnal HypoxemiaUnited States
-
Istinye UniversityNot yet recruitingPostoperative HypoxemiaTurkey (Türkiye)
-
Istinye UniversityNot yet recruitingPostoperative HypoxemiaTurkey (Türkiye)
-
University of CincinnatiUnited States Air ForceCompletedHypoxemia | Hypobaric HypoxemiaUnited States
-
General Hospital of Ningxia Medical UniversityRecruiting
-
University of CincinnatiWithdrawn
-
University Hospital, Clermont-FerrandCompletedPostoperative HypoxemiaFrance
-
Beth Israel Deaconess Medical CenterWellcome TrustRecruitingAcute HypoxemiaKenya, Malawi, Rwanda
-
Seoul National University HospitalCompleted